文献速递帕金森病与运动障碍认知障碍与痴呆

α-突触核蛋白病中快速眼动睡眠行为障碍的时间线分析

Timeline of Rapid Eye Movement Sleep Behavior Disorder in Overt Alpha-Synucleinopathies.
PubMed 文献 · Ann Neurol · 2020-11-20

基于1991-2010年人群发病队列,444例α-突触核蛋白病患者中19.8%临床诊断RBD,特发性RBD患病率从诊断时3.4%升至15年后23.8%,累积终生发病率是对照组的53倍,且不增加死亡风险。

要点

  • α-突触核蛋白病患者RBD累积终生发病率显著高于对照组(OR=53.1)。
  • 路易体痴呆患者RBD风险高于帕金森病(OR=2.57)。
  • 男性帕金森病、路易体痴呆或帕金森病痴呆患者RBD风险高于女性(OR=3.70)。

核心结论

  • α-突触核蛋白病患者RBD终生发病率远高于对照,路易体痴呆风险高于帕金森病,男性风险高于女性,但RBD未增加死亡风险。

研究设计与样本

  • 基于人群的1991至2010年发病队列研究,纳入444例α-突触核蛋白病(帕金森病、路易体痴呆、帕金森病痴呆)患者并与年龄性别匹配对照比较。

主要发现

  • 444例中86例(19.8%)临床诊断RBD,其中30例(35%)经多导睡眠图确诊,56例(65%)为很可能RBD。
  • 诊断α-突触核蛋白病时特发性RBD患病率为3.4%,15年后增至23.8%。
  • α-突触核蛋白病患者RBD累积终生发病率是对照组的53倍(OR=53.1,95%CI 13.0-217.2,p<0.0001)。
  • 路易体痴呆患者RBD风险高于帕金森病(OR=2.57,95%CI 1.50-4.40,p=0.0004)。
  • 男性帕金森病、路易体痴呆或帕金森病痴呆患者RBD风险高于女性(OR=3.70,95%CI 2.07-6.62,p<0.0001)。

关键数值与推荐

  • RBD诊断依据梦样行为症状报告或多导睡眠图,分为很可能RBD与多导睡眠图确诊RBD并分别及合并分析。
  • RBD总体发病率为2.5例/100人年。

临床怎么用

  • 对α-突触核蛋白病患者应关注RBD症状,尤其路易体痴呆和男性患者,但其存在不提示死亡风险升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim was to analyze the timeline, prevalence, and survival of rapid eye movement (REM) sleep behavior disorder (RBD) in patients who developed alpha-synucleinopathies (Parkinson disease, dementia with Lewy bodies, and Parkinson disease dementia) compared with age- and sex-matched controls in a population-based incident-cohort study. METHODS: We used a population-based, 1991 to 2010 incident-cohort study of alpha-synucleinopathies. A movement-disorder specialist reviewed medical records to confirm diagnoses. RBD was diagnosed by reported dream-enactment symptoms or polysomnography. Probable RBD and polysomnographically confirmed RBD were analyzed separately and combined. RESULTS: Among the 444 incident cases of alpha-synucleinopathy, 86 were clinically diagnosed with RBD (19.8%), including 30 (35%) by polysomnography and 56 (65%) as probable. The prevalence of idiopathic RBD at alpha-synucleinopathy diagnosis was 3.4%, increasing to 23.8% after 15 years. Cumulative lifetime incidence was 53 times greater in alpha-synucleinopathy patients than in controls (odds ratio [OR] = 53.1, 95% confidence interval [CI]: 13.0-217.2, p < 0.0001), higher in dementia with Lewy bodies than in Parkinson disease (OR = 2.57, 95% CI: 1.50-4.40, p = 0.0004), and higher in men than in women with Parkinson disease, dementia with Lewy bodies, or Parkinson disease dementia (OR = 3.70, 95% CI: 2.07-6.62, p < 0.0001), but did not increase mortality risk. INTERPRETATION: Our cohort had RBD incidence of 3.4%. Overall RBD increased to 23.8% after 15 years, with an overall incidence of 2.5 cases per 100 person-years. With 53 times greater lifetime incidence in alpha-synucleinopathy patients than in controls, RBD was more likely to develop in dementia with Lewy bodies than in Parkinson disease or Parkinson disease dementia, and in men than in women, but did not increase mortality risk within our cohort. ANN NEUROL 2021;89:293-303.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Stang CD, Mullan AF, Hajeb M, et al. Timeline of Rapid Eye Movement Sleep Behavior Disorder in Overt Alpha-Synucleinopathies. Ann Neurol. 2020. PMID: 33155696. doi:10.1002/ana.25952

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。